Truist Securities Maintains Hold on Cross Country Healthcare, Lowers Price Target to $22
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Tobey Sommer has maintained a 'Hold' rating on Cross Country Healthcare (NASDAQ:CCRN) and lowered the price target from $25 to $22.
November 02, 2023 | 7:40 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cross Country Healthcare's price target has been lowered from $25 to $22 by Truist Securities, while maintaining a 'Hold' rating.
The lowering of the price target for Cross Country Healthcare by Truist Securities indicates a potential decrease in the stock's value. The 'Hold' rating suggests that the stock is not expected to outperform the market in the near term, which could negatively impact investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100